December 1995
Vol 13 Issue 12 This month: Follow up letter to SmithKline Beecham re claims in Pakistan that Halfan (halofantrine) is "effective in all types of malaria", has an "excellent safety profile" and a "convenient dosage". News: Prescrire's sales representative monitoring network.
Our members can see and make comments on this page.
Please
Register
(read more)
then
Log in
for free access to more features of this website.
Forgot your username or password?
You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.
PharmedOut’s annual conference: Missing The Target: When Practitioners Harm More Than Heal
No Free Lunch is merging with Healthy Skepticism
Conference program: Pharma Knows Best? Managing Medical Knowledge
Prescrire’s proposals for France’s national conference on medicines policy
Pharmed Out Conference ‘Pharma Knows Best? Managing Medical Knowledge’
Next issue: IFPMA Ponstan (mefenemic acid)
Previous issue: Upjohn Lincomycin (linconmycin) and Dalacin C (clindamycin)
